These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 11246531

  • 1. High molecular weight kininogen deficiency: a patient who underwent cardiac surgery.
    Davidson SJ, Burman JF, Rutherford LC, Keogh BF, Yacoub MH.
    Thromb Haemost; 2001 Feb; 85(2):195-7. PubMed ID: 11246531
    [Abstract] [Full Text] [Related]

  • 2. Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin.
    van Veen JJ, Laidlaw S, Swanevelder J, Harvey N, Watson C, Kitchen S, Makris M.
    Eur J Haematol; 2009 Mar; 82(3):208-12. PubMed ID: 19077049
    [Abstract] [Full Text] [Related]

  • 3. Practical approach to anticoagulation for cardiopulmonary bypass in the patient with congenital prolonged activated partial thromboplastin time.
    Cankovic L, Steenwyk BL, McGiffin DC, Nielsen VG.
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):725-6. PubMed ID: 18832918
    [Abstract] [Full Text] [Related]

  • 4. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R, Marwaha G, Sinha P, Quantz M, Stitt L, Gao R, Subramanian S, Schaus M, Keeney M, Chin-Yee I, Murkin J.
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [Abstract] [Full Text] [Related]

  • 5. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ, Joist JH.
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [Abstract] [Full Text] [Related]

  • 6. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R.
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [Abstract] [Full Text] [Related]

  • 7. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
    Dauchot PJ, Berzina-Moettus L, Rabinovitch A, Ankeney JL.
    Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
    [Abstract] [Full Text] [Related]

  • 8. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT, Monn A, Tavakoli R, Genoni M, Klaghofer R, Furrer L, Honegger H, Hofer CK.
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [Abstract] [Full Text] [Related]

  • 9. Hemofiltration removes bradykinin generated in the priming blood in cardiopulmonary bypass during circulation.
    Sakurai H, Maeda M, Murase M, Koyama T, Hayakawa M.
    Ann Thorac Cardiovasc Surg; 1998 Apr; 4(2):59-63. PubMed ID: 9576999
    [Abstract] [Full Text] [Related]

  • 10. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R, Jacobs C.
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [Abstract] [Full Text] [Related]

  • 11. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ, Bös M, Weber D, Winkler K, Hanfland P, Preusse CJ.
    Semin Thromb Hemost; 2005 Apr; 31(4):426-40. PubMed ID: 16149021
    [Abstract] [Full Text] [Related]

  • 12. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, Fries D, Innerhofer P.
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [Abstract] [Full Text] [Related]

  • 13. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS, Murkin JM, Adams SJ.
    Heart Surg Forum; 2004 Mar; 7(6):E599-604. PubMed ID: 15769695
    [Abstract] [Full Text] [Related]

  • 14. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
    Daudt CA, Pereira SN, Moraes LB, Costa PS, Deboni LM, Figueiredo MS.
    Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
    [Abstract] [Full Text] [Related]

  • 15. Implications for cardiac surgery in patients with factor XII deficiency.
    Conaglen PJ, Akowuah E, Theodore S, Atkinson V.
    Ann Thorac Surg; 2010 Feb; 89(2):625-6. PubMed ID: 20103363
    [Abstract] [Full Text] [Related]

  • 16. [Activated coagulation time and the concentration of heparin in assessing the level of blood heparinization during operations using artificial blood circulation].
    Khodas MIa, Piatnitskaia GKh, Savina ME, Smirnova LA.
    Anesteziol Reanimatol; 1989 Feb; (2):11-5. PubMed ID: 2742179
    [Abstract] [Full Text] [Related]

  • 17. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H, Videm V, Wahba A, Asberg A, Amundsen T, Bjella L, Dale O, Stenseth R.
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [Abstract] [Full Text] [Related]

  • 18. Heparin monitoring during cardiac surgery. Part 2: Calculating the overestimation of heparin by the activated clotting time.
    Raymond PD, Ray MJ, Callen SN, Marsh NA.
    Perfusion; 2003 Sep; 18(5):277-81. PubMed ID: 14604243
    [Abstract] [Full Text] [Related]

  • 19. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M, Toh CH, Thachil J, Watson HG.
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [Abstract] [Full Text] [Related]

  • 20. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT, Monn A, Tavakoli R, Klaghofer R, Zollinger A, Hofer CK.
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.